

Post Audit - Pre Strategy
The direction is due to be set over the coming months when Life Science Nord defines the cluster's strategic objectives together with the political, business and scientific players. "We will have to deal with highly topical subjects such as digitalization in the life sciences in particular," stresses Schleswig-Holstein's minister for economic affairs Dr. Bernd Buchholz. He says the process will involve addressing challenges such as cooperation across cluster borders (cross clusters) and providing greater support to such structures. "In the future, it will become increasingly necessary to collaborate with other sectors in order to develop successful solutions."About the Gold Label
The "Cluster Organisation Management Excellence Label GOLD - Proven for Cluster Excellence" is awarded by the European Cluster Excellence Initiative (ECEI). It was developed in 2009 on the initiative of the European Commission with the aim of creating an independent, voluntary process to assess the quality of cluster managements that applies throughout Europe. Organizations from 13 European countries with extensive knowledge in cluster management and cluster policy are represented in the initiative. To qualify for the GOLD Label, the participating cluster management organizations are required to demonstrate expertise in various "levels of excellence". Besides the organizational structure, management and funding of the cluster, its strategy, services offered and public visibility are also covered. More under: www.cluster-analysis.orgMore News

Pacira BioSciences Acquires GQ Bio
HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...
Read more …
CrystalsFirst Scales Operations...
CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...
Read more …
Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT
medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...
Read more …